Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference
NEWTON, Mass., Jan. 3, 2024 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company’s senior management team will participate at the 42nd Annual J.P. Morgan Healthcare Conference in a podium presentation on Wednesday, January 10 at 2:15 p.m. PT, followed by a question-and-answer breakout session at 2:35 p.m. PT.
Related news for (KPTI)
- Today’s Top Performers: MoBot’s Market Review 08/15/25 01:00 PM
- Breaking News: MoBot’s Latest Update as of 08/15/25 12:00 PM
- Karyopharm Therapeutics Provides Endometrial Cancer Program Update
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives